Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.
Jönsson
B
B
Stockholm School of Economics, Box 6501, SE 11383 Stockholm, Sweden. Bengt.Jonsson@hhs.se
Ström
O
O
Eisman
J A
JA
Papaioannou
A
A
Siris
E S
ES
Tosteson
A
A
Kanis
J A
JA